Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Total 13F shares
-
175,028,482
-
Share change
-
+519,464
-
Total reported value
-
$13,525,852,754
-
Put/Call ratio
-
187%
-
Price per share
-
$77.29
-
Number of holders
-
493
-
Value change
-
+$32,397,316
-
Number of buys
-
225
-
Number of sells
-
205
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q3 2021
As of 30 Sep 2021,
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) was held by
493 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
175,028,482 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, Capital Research Global Investors, VANGUARD GROUP INC, BlackRock Inc., Dodge & Cox, BAKER BROS. ADVISORS LP, AMERIPRISE FINANCIAL INC, Clearbridge Investments, LLC, STATE STREET CORP, and JANUS HENDERSON GROUP PLC.
This page lists
502
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.